Brian Wigdahl, Ph.D., is professor and chair of Microbiology and Immunology, director of the Institute for Molecular Medicine and Infectious Disease, and director of the institutes Center for Molecular Virology and Translational Neuroscience at the Drexel University College of Medicine. An internationally recognized molecular virologist, Dr. Wigdahl focuses his immediate research on the molecular mechanisms, treatment, and prevention of immunologic abnormalities, cancer, and progressive neurologic disorders caused by members of the retrovirus and herpesvirus families. He has a total of more than 180 published or in press peer-reviewed publications. Dr. Wigdahl has been funded by the National Institutes of
Brian Wigdahl, Ph.D., is professor and chair of Microbiology and Immunology, director of the Institute for Molecular Medicine and Infectious Disease, and director of the institutes Center for Molecular Virology and Translational Neuroscience at the Drexel University College of Medicine. An internationally recognized molecular virologist, Dr. Wigdahl focuses his immediate research on the molecular mechanisms, treatment, and prevention of immunologic abnormalities, cancer, and progressive neurologic disorders caused by members of the retrovirus and herpesvirus families. He has a total of more than 180 published or in press peer-reviewed publications. Dr. Wigdahl has been funded by the National Institutes of Health and other agencies, foundations, commercial sources for over 35 years, with awards totaling more than $40 million. A senior associate editor of the Journal of NeuroVirology, Dr. Wigdahl also served for six years as president of the International Society for NeuroVirology, and currently serves as treasurer of the Society. During his time at Penn State, Dr. Wigdahl was awarded the Samuel Hinkle Society Outstanding Young Investigator award and more recently at Drexel University College of Medicine, the Julian Marsh, MD, Faculty Scholar Award for excellence in scientific research, outstanding teaching skills, and consistent high quality leadership. Dr. Wigdahl is the 2013 recipient of the International Society for NeuroVirology Pioneer in Neurovirology Award presented in recognition of outstanding individual achievement in the field of neurovirology.
Dr. Aimin Zhou is a professor at the Department of Chemistry, Cleveland State University and an adjunct staff at the Department of Cancer Biology, Cleveland Clinic since 2000. Before he joined CSU, Dr. Zhou was working in the Department of Cancer Biology, Cleveland Clinic, to study the role of RNase L in interferon functions against viral infection and cell proliferation. He cloned the RNase L gene and created an RNase L knock out mouse. By using the animal model, he has demonstrated that RNase L was able to inhibit certain viruses and the ectopic expression of RNase L significantly suppressed
Dr. Aimin Zhou is a professor at the Department of Chemistry, Cleveland State University and an adjunct staff at the Department of Cancer Biology, Cleveland Clinic since 2000. Before he joined CSU, Dr. Zhou was working in the Department of Cancer Biology, Cleveland Clinic, to study the role of RNase L in interferon functions against viral infection and cell proliferation. He cloned the RNase L gene and created an RNase L knock out mouse. By using the animal model, he has demonstrated that RNase L was able to inhibit certain viruses and the ectopic expression of RNase L significantly suppressed tumor growth in athymic mice. Currently, his research is to focus on studying the role of RNase L in inflammatory diseases.
Mazhar I. Khan is a Professor of Pathobiolgy at the University of Connecticut (UConn). Currently the major research aims in his laboratory located at the Department of Pathobiology & Veterinary Science is the development of DNA based molecular diagnostic tests and vaccines for avian pathogens such as avian influenza, infectious bronchitis viruses. Currently he is involved in the development of innovative bioinformatics tool for viral quasispecies reconstruction using next generation sequencing data for the development of optimized vaccines. He is also developing and testing nanoparticle based avian influenza (bird flu) vaccine. M. Khan has long-term experience in development and application
Mazhar I. Khan is a Professor of Pathobiolgy at the University of Connecticut (UConn). Currently the major research aims in his laboratory located at the Department of Pathobiology & Veterinary Science is the development of DNA based molecular diagnostic tests and vaccines for avian pathogens such as avian influenza, infectious bronchitis viruses. Currently he is involved in the development of innovative bioinformatics tool for viral quasispecies reconstruction using next generation sequencing data for the development of optimized vaccines. He is also developing and testing nanoparticle based avian influenza (bird flu) vaccine. M. Khan has long-term experience in development and application of DNA probe, PCR, multiplex PCR and real-time PCR methods for rapid detecting of viral pathogens in clinical samples since 1987. He made contributions in the diagnostic field by early applications of DNA techniques in identification of several pathogens of avian and animal diseases.
Professor Zhou is presently the Associate Vice President of Global Medical Development & Associate Dean of International Research, College of Pharmacy, University of South Florida, Tampa (USF), Florida. USF is one of only 25 public research universities nationwide with very high research activity that is also designated as community engaged by the Carnegie Foundation for the Advancement of Teaching. USF is a global research university ranked 34th in federal research expenditures for public universities and is one of the fastest growing in federal funding in the US. Professor Zhou completed his clinical medical training in China in 1989 and obtained
Professor Zhou is presently the Associate Vice President of Global Medical Development & Associate Dean of International Research, College of Pharmacy, University of South Florida, Tampa (USF), Florida. USF is one of only 25 public research universities nationwide with very high research activity that is also designated as community engaged by the Carnegie Foundation for the Advancement of Teaching. USF is a global research university ranked 34th in federal research expenditures for public universities and is one of the fastest growing in federal funding in the US. Professor Zhou completed his clinical medical training in China in 1989 and obtained his PhD in 2001 from the School of Medicine, the University of Auckland, New Zealand. Since 2002, Dr Zhou has served as an Assistant Professor, Senior Lecturer, Associate Professor and Professor for the National University of Singapore, Queensland University of Technology, RMIT University in Australia, and now at USF. Dr Zhous major research interests are systems pharmacology, drug metabolism & drug transport, pharmacokinetics/pharmacometrics, pharmacogenomics, nanomedicine and Chinese medicine.
Dr. Alireza Heidari is a Full Distinguished Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his PhD. and DSc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nano chemistry and Modern Molecular Electronic-Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nano chemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational
Dr. Alireza Heidari is a Full Distinguished Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his PhD. and DSc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nano chemistry and Modern Molecular Electronic-Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nano chemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti-Cancer Nano Drugs, Nano Drugs Delivery, ATR-FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc.
Mojgan Haddad received her PhD in Computer Science and Medical Informatics from the Vienna University of Technology in Austria in 1996. She was an assistant professor at the University of Vienna before moving to San Francisco, CA. She performed a post-doctorate study at the University of California San Francisco (UCSF) at the department of Microbiology & Immunology in Computational/Mathematical biology. She then joined Monogram Biosciences, and was the head of the Bioinformatics/Biostatistics department until January 2014. Dr. Haddad currently holds the position of Senior Director, Bioinformatics & Analytics at HealthTell, Inc, which is an early stage start-up company that is
Mojgan Haddad received her PhD in Computer Science and Medical Informatics from the Vienna University of Technology in Austria in 1996. She was an assistant professor at the University of Vienna before moving to San Francisco, CA. She performed a post-doctorate study at the University of California San Francisco (UCSF) at the department of Microbiology & Immunology in Computational/Mathematical biology. She then joined Monogram Biosciences, and was the head of the Bioinformatics/Biostatistics department until January 2014. Dr. Haddad currently holds the position of Senior Director, Bioinformatics & Analytics at HealthTell, Inc, which is an early stage start-up company that is developing powerful new tools to help individuals monitor their health status based on measuring the bodys immune response to a given disease or disease state. Dr. Haddads research interests are bioinformatics, biostatistics, applied mathematics, and artificial intelligence within the fields of virology, oncology, immunology, and proteomics.
Harold C. Smith is a graduate of Purdue University and holds graduate degrees from Purdue and the State University of NY at Buffalo. He carried out postdoctoral studies at Baylor College of Medicine, Houston, TX. He is professor of Biochemistry and Biophysics with the University of Rochester. He has published more than 100 papers in reputed journals and contributes to curriculum development and teaching of undergraduates, graduate students and medical students at the University. He is also founder and Chief Scientific Office of OyaGen, Inc. Strengths are in viral restriction factors and host defense, drug discovery and preclinical drug development.
Harold C. Smith is a graduate of Purdue University and holds graduate degrees from Purdue and the State University of NY at Buffalo. He carried out postdoctoral studies at Baylor College of Medicine, Houston, TX. He is professor of Biochemistry and Biophysics with the University of Rochester. He has published more than 100 papers in reputed journals and contributes to curriculum development and teaching of undergraduates, graduate students and medical students at the University. He is also founder and Chief Scientific Office of OyaGen, Inc. Strengths are in viral restriction factors and host defense, drug discovery and preclinical drug development.
Dr. Yasuhiro Yamamura is a virologist/immunologist, who has been the professor of microbiology and the director of AIDS Research Program at the Ponce School of Medicine and Health Sciences (Ponce, Puerto Rico) since late 80s. He obtained his Ph.D. degree from the University of Michigan (Ann Arbor, MI) in Epidemiologic Sciences and worked in the fields of Cancer (cellular) Immunology before starting his work in HIV/AIDS related fields. His recent efforts have focused on the development of HIV/AIDS research collaboration network among the scientists in the Caribbean countries. His current research interests include HIV molecular epidemiology, HIV compartmentalization and also
Dr. Yasuhiro Yamamura is a virologist/immunologist, who has been the professor of microbiology and the director of AIDS Research Program at the Ponce School of Medicine and Health Sciences (Ponce, Puerto Rico) since late 80s. He obtained his Ph.D. degree from the University of Michigan (Ann Arbor, MI) in Epidemiologic Sciences and worked in the fields of Cancer (cellular) Immunology before starting his work in HIV/AIDS related fields. His recent efforts have focused on the development of HIV/AIDS research collaboration network among the scientists in the Caribbean countries. His current research interests include HIV molecular epidemiology, HIV compartmentalization and also the impacts of chronic inflammation on the development of mental-cognitive disorders in patients with chronic physical illness including chronic treatment phase of HIV-infection. His laboratory is WHO HIVResNet-accredited for the global HIV drug resistance mutation surveillance and monitoring program, and provides technical training for the Caribbean HIV laboratory scientists/technologists in HIV molecular diagnosis. Using next generation sequencing, his laboratory performs metagenomics analysis of gut, oral as well as blood-borne bacteria involved in inflammatory processes. His trans-disciplinary research team includes clinical investigators, epidemiologists, clinical psychologists/psychiatrists as well as biomedical research investigators.
Dharam V. Ablashi is an American biomedical researcher. He has co-authored 96 articles on HHV-6 and over 300 scientific articles on herpesviruses and HIV. His major interests are assessing pathogenic roles of viruses in diseases and in developing diagnostic, prognostic and therapeutic reagents to combat malignant and non-malignant infections. He has a BSc (Biology) and a D.M.V degree from Panjab University India, a Diploma in Bacteriology from I.V.R.I and a MS in Virology/Pathology from the University of Rhode Island. He joined NIH/NCI in 1969 working on human and simian herpesviruses. In 1986, he co-discovered human herpesvirus-6 (HHV-6), a highly neurotropic
Dharam V. Ablashi is an American biomedical researcher. He has co-authored 96 articles on HHV-6 and over 300 scientific articles on herpesviruses and HIV. His major interests are assessing pathogenic roles of viruses in diseases and in developing diagnostic, prognostic and therapeutic reagents to combat malignant and non-malignant infections. He has a BSc (Biology) and a D.M.V degree from Panjab University India, a Diploma in Bacteriology from I.V.R.I and a MS in Virology/Pathology from the University of Rhode Island. He joined NIH/NCI in 1969 working on human and simian herpesviruses. In 1986, he co-discovered human herpesvirus-6 (HHV-6), a highly neurotropic and immune suppressive virus causing neurological disorders. He retired from NIH after 23 years and became an adjunct professor at Georgetown University School of Medicine (1986-2008) and directed herpesvirus programs at a biomedical technology company (1994-2002). He has been the Scientific Director of the HHV-6 Foundation since 2004 and recently became the Senior Technology Officer of fiteBac Technology in Marietta, Georgia.
Dr. Abubaker ME. Sidahmed is a Professor of Medicine and Pathobiolgy with MD, MSc and PhD from University of Toronto Canada. Dr. Sidahmed recently joined the Department of Pathology and Laboratory Medicine at University of Calgary. Currently his major research interest is the host immune to viral infection particularly West Nile Virus, Influenza and HIV, the development of molecular based diagnostic tests and vaccines for viral pathogens such as influenza and West Nile Viruses. In addition, his research interest includes genes expression in aging and their effects in susceptibility to viral infection, SNPs genotyping and their association with viral
Dr. Abubaker ME. Sidahmed is a Professor of Medicine and Pathobiolgy with MD, MSc and PhD from University of Toronto Canada. Dr. Sidahmed recently joined the Department of Pathology and Laboratory Medicine at University of Calgary. Currently his major research interest is the host immune to viral infection particularly West Nile Virus, Influenza and HIV, the development of molecular based diagnostic tests and vaccines for viral pathogens such as influenza and West Nile Viruses. In addition, his research interest includes genes expression in aging and their effects in susceptibility to viral infection, SNPs genotyping and their association with viral infections, Conditional and conventional Knockout mice generation and characterization, Cytokine and chemokine roles in host immune response to against viral infection, siRNA artificial control of cytokine and chemokine genes expression and HLA and disease association
Gian Maria Pacifici achieved the PhD in Biological Sciences at the University of Pisa, Pisa, Italy, in 1971, and the PhD in Medical Sciences at the Karolinska Institutet, Stockholm, Sweden, in 1983. He held the permanent position of Associate Professor of Pharmacology, Department of Pharmacology, Medical School, University of Pisa, Pisa, Italy.
Gian Maria Pacifici achieved the PhD in Biological Sciences at the University of Pisa, Pisa, Italy, in 1971, and the PhD in Medical Sciences at the Karolinska Institutet, Stockholm, Sweden, in 1983. He held the permanent position of Associate Professor of Pharmacology, Department of Pharmacology, Medical School, University of Pisa, Pisa, Italy.
Professor, Clinical Director of Internal Medicine Department of Internal Medicine University of Ulm Germany
Huan-Zhang Zhu Professor in Pathology from Third Military Medical University, China, in 2000. Post-doctoral fellow at University of British Columbia from 2005 to 2006; Presently, work at State Key Laboratory of Genetic Engineering, Institute of Genetics, Fudan University, since 2006. Current research is to understand the molecular mechanisms of HIV proviral latency and develop novel therapeutic strategies to eliminate the latent population. Zhu Lab found that histone methyltransferase GLP may play a significant role in the maintenance of HIV-1 latency by catalyzing dimethylation of H3K9, and also found that a single ZFN-LTR pair can specifically and effectively cleave integrated
Huan-Zhang Zhu Professor in Pathology from Third Military Medical University, China, in 2000. Post-doctoral fellow at University of British Columbia from 2005 to 2006; Presently, work at State Key Laboratory of Genetic Engineering, Institute of Genetics, Fudan University, since 2006. Current research is to understand the molecular mechanisms of HIV proviral latency and develop novel therapeutic strategies to eliminate the latent population. Zhu Lab found that histone methyltransferase GLP may play a significant role in the maintenance of HIV-1 latency by catalyzing dimethylation of H3K9, and also found that a single ZFN-LTR pair can specifically and effectively cleave integrated full-length HIV-1proviral DNA and mediate antiretroviral activity in infected and latently infected cells. His research interests are Using molecular genetics, epigenetics, genetic engineering and immunology, to understand the molecular mechanisms of HIV-1 persistence, to develop novel biological therapy technology and candidate drug for anti HIV therapies.
Dr. Demin Zhou is a full professor at the School of Pharmaceutical Sciences, Peking University Health Science Center, China since 2008. Before he joined PKU, Dr. Zhou has been working in several biotech and pharmaceutical companies in USA wherein his research has been focused on viral target discovery and validation via emerging biotechnologies. His current interests include design, synthesis and characterization of novel small molecules with a focus on blocking virus-host interaction and recognition and thus the treatment of virus infections.
Dr. Demin Zhou is a full professor at the School of Pharmaceutical Sciences, Peking University Health Science Center, China since 2008. Before he joined PKU, Dr. Zhou has been working in several biotech and pharmaceutical companies in USA wherein his research has been focused on viral target discovery and validation via emerging biotechnologies. His current interests include design, synthesis and characterization of novel small molecules with a focus on blocking virus-host interaction and recognition and thus the treatment of virus infections.
Guangwei Liu got his MD and PhD degree in Jilin University 2004 in China. He performed the postdoctoral research from 2004-2006 in the Institute of Zoology, Chinese Academy of Sciences (CAS) and 2007-2010 in the Department of Immunology, St. Jude Childrens Hospital, USA. Now he is working in the Fudan University, China, as a professor, still working in the immunological field. Dr. Guangwei Lius research area is focused on Immune Modulation. The research studies involve immune regulatory regularities and mechanisms of diseases and provide the insight for the potential immune biological therapy for diseases. They used a combination of approaches
Guangwei Liu got his MD and PhD degree in Jilin University 2004 in China. He performed the postdoctoral research from 2004-2006 in the Institute of Zoology, Chinese Academy of Sciences (CAS) and 2007-2010 in the Department of Immunology, St. Jude Childrens Hospital, USA. Now he is working in the Fudan University, China, as a professor, still working in the immunological field. Dr. Guangwei Lius research area is focused on Immune Modulation. The research studies involve immune regulatory regularities and mechanisms of diseases and provide the insight for the potential immune biological therapy for diseases. They used a combination of approaches including mouse genetics, cellular immunology and biochemistry, as well as models of infectious, tumor, autoimmune and transplantation and incorporation with clinical with patient samples. They majorly explored the regulatory regularity and mechanisms of T and myeloid-derived innate immune cell development, differentiation and function, especially interested in the S1P1-AKT-mTOR signaling pathway.His research interests are T cell development, differentiation and modulation; Myeloid-derived cell development, differentiation and modulation; Immunomodulation of macrophages and neutrophils in the virus inflammation; Cell and molecular basis of immune tolerance, particularly in the virus infection; Cell and molecular mechanisms of infectious inflammation.
Jie Zheng is a professor of Pathology at Medical School of Southeast University, Nanjing, China. He graduated from Wannan Medical College, received his master degree from Nanjing Railway Medical College and earn his doctoral degree from University of Helsinki. His post-doctoral work was carried out in Peking Union Medical College and University of Michigan. He has worked in the various areas of cancer biology, such as, human papillomaviruses and human cervical cancer, anti-cancer effect of arsenic trioxide and celecoxib, hedgehog signaling and human cancer, osteopontin role in human cancer, etc. He has published more than 120 peer-reviewed papers and 5
Jie Zheng is a professor of Pathology at Medical School of Southeast University, Nanjing, China. He graduated from Wannan Medical College, received his master degree from Nanjing Railway Medical College and earn his doctoral degree from University of Helsinki. His post-doctoral work was carried out in Peking Union Medical College and University of Michigan. He has worked in the various areas of cancer biology, such as, human papillomaviruses and human cervical cancer, anti-cancer effect of arsenic trioxide and celecoxib, hedgehog signaling and human cancer, osteopontin role in human cancer, etc. He has published more than 120 peer-reviewed papers and 5 books (including co-authors). He is an expert for National Scientific Foundation and several other organizations. He is also a member of the Guidepoint Global Advisors.
Dr. Seong received the Bachelor degree from Seoul National University in 1977, the master degree in 1979 from KAIST, Seoul, Korea, and PhD in 1988 from Massachusetts Institute of Technology, USA. Then he moved to University of Oxford, England, where he initiated the influenza virus research. As an initiating scientist of Aviron, a venture company in Palo Alto, CA, he was involved in live influenza virus vaccine. He served as director of Hanhyo Institute of Biological Science for five years, and from 1998, he has been the faculty member of Yonsei University. As director of Vaccine Translational Research Center, he
Dr. Seong received the Bachelor degree from Seoul National University in 1977, the master degree in 1979 from KAIST, Seoul, Korea, and PhD in 1988 from Massachusetts Institute of Technology, USA. Then he moved to University of Oxford, England, where he initiated the influenza virus research. As an initiating scientist of Aviron, a venture company in Palo Alto, CA, he was involved in live influenza virus vaccine. He served as director of Hanhyo Institute of Biological Science for five years, and from 1998, he has been the faculty member of Yonsei University. As director of Vaccine Translational Research Center, he currently dedicates his research efforts on vaccine development for infectious diseases and molecular pathogenesis of influenza infection. Research Interests are Molecular pathogenesis of influenza infection, Live attenuated vaccine design, Pandemic influenza vaccine development, RNA-dependent molecular chaperone.
After graduation in Medicine, prof. Balsano started her career focusing both on liver research and clinical diagnostic studies. From 1989 to 1992 collaborated with the Biochimie Genetique laboratory, Hospital Cochin in Paris, direct by Dr. Pascale Briand. In 1992, she became Associate Professor of Internal Medicine of LAquila University, and in 1993 director of Clinical and Biomolecular Hepatology Unit. From 2001 Prof. Balsano became the chief of Viral and Molecular Oncology laboratory of A. Cesalpino Foundation. In 2007, she became full Professor of Internal Medicine at LAquila University. In light of her expertise in liver diseases, in 2008 she was
After graduation in Medicine, prof. Balsano started her career focusing both on liver research and clinical diagnostic studies. From 1989 to 1992 collaborated with the Biochimie Genetique laboratory, Hospital Cochin in Paris, direct by Dr. Pascale Briand. In 1992, she became Associate Professor of Internal Medicine of LAquila University, and in 1993 director of Clinical and Biomolecular Hepatology Unit. From 2001 Prof. Balsano became the chief of Viral and Molecular Oncology laboratory of A. Cesalpino Foundation. In 2007, she became full Professor of Internal Medicine at LAquila University. In light of her expertise in liver diseases, in 2008 she was selected as Regional delegate for the Abruzzos region of Italian association for the Study on liver (AISF). From 2009, she collaborates with the Italian Ministry of Research, and from 2012 is the director of the Institute of Biology and Molecular Pathology (IBPM) of the National Council of Research (CNR). From 2014, she is an expert for the European Medicine Agency (EMA). Her research interests are Molecular characterization of Hepatitis B Virus. Diagnostic and clinical aspects of chronic HBV, Diagnostic and clinical aspects of chronic HCV, Immune answer to hepatic viruses infections, Role of viral proteins in inducing autoimmune diseases and chronic infection and new treatments for autoimmune hepatitis, Etiopathogenesis of hepatocarcinoma: molecular characterization, Molecular biology of intracellular transduction pathways, especially IFN- signaling, MAPKs pathway, PI3K-mTOR pathway, p53 superfamily pathways, impact of pollution on the liver health, Healthy effects of natural polyphenols against metabolic disorders.
Prof. Maurizio Botta, PhD (U.N.B.-Canada) is full Professor of Medicinal Chemistry at the department of Biotechnology, Chemistry and Pharmacy of University of Siena, from November 1st 2009 to December 2012 was Dean of the Faculty of Pharmacy and, from January 1st 2008, Adjunct Professor in Temple Universitys College of Science and Technology, in the Department of Biology, Philadelphia (USA). From 2002 to 2008 has been Head of the Dipartimento Farmaco Chimico Tecnologico of the University of Siena.EU expert for reviewing several projects, Cost Actions Reviewer, projects reviewer for Italian, Slovenian Research Projects, for the Wissenschaftsfonds-FWF, for the Cancer Research UK
Prof. Maurizio Botta, PhD (U.N.B.-Canada) is full Professor of Medicinal Chemistry at the department of Biotechnology, Chemistry and Pharmacy of University of Siena, from November 1st 2009 to December 2012 was Dean of the Faculty of Pharmacy and, from January 1st 2008, Adjunct Professor in Temple Universitys College of Science and Technology, in the Department of Biology, Philadelphia (USA). From 2002 to 2008 has been Head of the Dipartimento Farmaco Chimico Tecnologico of the University of Siena.EU expert for reviewing several projects, Cost Actions Reviewer, projects reviewer for Italian, Slovenian Research Projects, for the Wissenschaftsfonds-FWF, for the Cancer Research UK Programme, for Fondazione Roma, for the French National Research Agency and for Italian Ministery for the Economic Development. He is Member of the Editorial Board for ChemMedChem, J.Med.Chem, J.Chem.Inf. Model.and He is Associate Editor for ACS Med. Chem. Lett. He was Chairman of a number of scientific schools and meetings. Received five Merck Research Laboratories Awards Academic Development Program in Chemistry, and in 2014, the Medaglia Pratesi of the Italian Chemical Society. Since 1988, Prof. Botta is the owner of research funds granted by University, MIUR, CNR, EU, and Pharmaceutical Companies. Professor Botta is the author of about 460 papers, 9 publications on volumes, 25 patents.
Dr. Yefei Zhu, is the Deputy Chief and Team Lead for the Outbreak Response Team in the Department of Acute Infectious Diseases Outbreak Response and Prevention, Jiangsu Provincial Center for Disease Control and Prevention in China. During his 8 years with the Jiangsu CDC, Dr. Zhu focused his efforts on investigating outbreaks of human illnesses caused by pathogens, including Escherichia coli O157:H7, norovirus, avian influenza (H7N9) virus, et al. He received his M.D. degree from Nanjing Medical University, Nanjing, China in 2006. He was board certified as associate professor in the School of Public Health, Nanjing Medical University, Nanjing, China
Dr. Yefei Zhu, is the Deputy Chief and Team Lead for the Outbreak Response Team in the Department of Acute Infectious Diseases Outbreak Response and Prevention, Jiangsu Provincial Center for Disease Control and Prevention in China. During his 8 years with the Jiangsu CDC, Dr. Zhu focused his efforts on investigating outbreaks of human illnesses caused by pathogens, including Escherichia coli O157:H7, norovirus, avian influenza (H7N9) virus, et al. He received his M.D. degree from Nanjing Medical University, Nanjing, China in 2006. He was board certified as associate professor in the School of Public Health, Nanjing Medical University, Nanjing, China in 2009. My research interests draw on the interplay between epidemiology and public health. My research has focused on the epidemiology of infectious diseases, with recent emphasis on molecular and geographic applications in Jiangsu, China. My research involves extensive collaboration with colleagues from other disciplines, including microbiology, geography, public health, climate change, et al.
Master Degree in Medicine and Surgery: University of Sapienza, Rome (1995). Specialization in Infectious Disease: University of Messina (2000). During his specialization studies he was visiting researcher, at University of Edinburgh (1998). As a Specialist he was at Spallanzani IRCCS and many other national institutions. Since 2001 he is medical doctor at Annunziata Hospital in Cosenza (ITALY) and from 2010 is responsible of HIV observatory and HIV-HCV coinfected patients. Today Dr Luciani is Chair of the Infectious Disease Unit of Annunziata Hospital. Member of SIMIT; SIE; IAS and CIO of Annunziata Hospital. Recently Dr. Luciani has implemented a three-year project
Master Degree in Medicine and Surgery: University of Sapienza, Rome (1995). Specialization in Infectious Disease: University of Messina (2000). During his specialization studies he was visiting researcher, at University of Edinburgh (1998). As a Specialist he was at Spallanzani IRCCS and many other national institutions. Since 2001 he is medical doctor at Annunziata Hospital in Cosenza (ITALY) and from 2010 is responsible of HIV observatory and HIV-HCV coinfected patients. Today Dr Luciani is Chair of the Infectious Disease Unit of Annunziata Hospital. Member of SIMIT; SIE; IAS and CIO of Annunziata Hospital. Recently Dr. Luciani has implemented a three-year project supported by the Italian Ministry of Health entitled: New tools for Biomolecular Murine typhus diagnosis and a project regarding HIV infected individuals on boosted PIs monotherapy.
Dr. Kumars major area of research interest is in infectious diseases, specifically viral immunopathogenesis and virus-host interactions. He conducts research on various emerging pathogens including West Nile virus, Japanese Encephalitis virus and hantaviruses using cell culture models, mouse models and biological specimens. His work encompasses both basic research in trying to understand more thoroughly how these agents cause disease and how the human immune system responds to these infections, and more directed research in developing and evaluating vaccines and other tools to prevent infection by these agents. His work also involves developing novel small animal models to study infectious pathogens.
Dr. Kumars major area of research interest is in infectious diseases, specifically viral immunopathogenesis and virus-host interactions. He conducts research on various emerging pathogens including West Nile virus, Japanese Encephalitis virus and hantaviruses using cell culture models, mouse models and biological specimens. His work encompasses both basic research in trying to understand more thoroughly how these agents cause disease and how the human immune system responds to these infections, and more directed research in developing and evaluating vaccines and other tools to prevent infection by these agents. His work also involves developing novel small animal models to study infectious pathogens. Dr. Kumar has published several outstanding papers in top international journals and his research findings are widely cited.
My background is geo-computation and spatial data mining. My current research focuses on spatiotemporal modeling of infectious diseases. My previous project has developed methods and a software package to capture and model space-time activities of individuals related to influenza transmission. My current research investigates spatiotemporal transmission of influenza in densely populated Chinese cities and the development of software and hardware to model close-contact characteristics in densely populated communities for individual based infectious disease modeling. Such models will help evaluating the effects of various prevention and control strategies and guide the surveillance of infectious diseases.
My background is geo-computation and spatial data mining. My current research focuses on spatiotemporal modeling of infectious diseases. My previous project has developed methods and a software package to capture and model space-time activities of individuals related to influenza transmission. My current research investigates spatiotemporal transmission of influenza in densely populated Chinese cities and the development of software and hardware to model close-contact characteristics in densely populated communities for individual based infectious disease modeling. Such models will help evaluating the effects of various prevention and control strategies and guide the surveillance of infectious diseases.
Dr James Maclean is a Principal Scientist and has been the Molecular Biology Head at Planet Biotechnology (California, USA) since 2007. He obtained a PhD from the Division of Medical Virology at the University of Cape Town (South Africa), where he worked on developing inexpensive human papillomavirus (HPV) vaccines using recombinant BCG (the live mycobacterial vaccine for tuberculosis). After his PhD, Dr Maclean went on to work as a Senior Scientific Officer in the Plant Vaccine Group, Dept. of Molecular & Cell Biology, University of Cape Town (South Africa), where he worked on vaccines for HIV, HPV and H5N1, and
Dr James Maclean is a Principal Scientist and has been the Molecular Biology Head at Planet Biotechnology (California, USA) since 2007. He obtained a PhD from the Division of Medical Virology at the University of Cape Town (South Africa), where he worked on developing inexpensive human papillomavirus (HPV) vaccines using recombinant BCG (the live mycobacterial vaccine for tuberculosis). After his PhD, Dr Maclean went on to work as a Senior Scientific Officer in the Plant Vaccine Group, Dept. of Molecular & Cell Biology, University of Cape Town (South Africa), where he worked on vaccines for HIV, HPV and H5N1, and gained experience in Molecular Pharming (using genetically modified plants to produce pharmaceuticals). At Planet Biotechnology, Dr Maclean does both contract manufacturing and research and development of novel therapeutics, mainly in the field of infectious diseases.
Dr Mas obtained his PhD (1997) under the supervision of Dr Vicente Soriano (Hospital Carlos III, Madrid, Spain) working on unusual strains of HIV. After PhD, Dr Mas joined Dr Esteban Domingos lab for a postdoctoral stay (1998-2002) working on HIV variability and reverse transcriptase resistance mechanisms. From 2003 to 2005 Dr Mas was contracted as an Assistant Professor of Microbiology at University Pompeu Fabra (Barcelona, Spain) under the supervision of Dr Juan Diez. Since 2006, Dr Mas is part of the University of Castilla-La Mancha (Albacete, Spain) working on different aspects of HCV infection including NS5B HCV polymerase. Currently,
Dr Mas obtained his PhD (1997) under the supervision of Dr Vicente Soriano (Hospital Carlos III, Madrid, Spain) working on unusual strains of HIV. After PhD, Dr Mas joined Dr Esteban Domingos lab for a postdoctoral stay (1998-2002) working on HIV variability and reverse transcriptase resistance mechanisms. From 2003 to 2005 Dr Mas was contracted as an Assistant Professor of Microbiology at University Pompeu Fabra (Barcelona, Spain) under the supervision of Dr Juan Diez. Since 2006, Dr Mas is part of the University of Castilla-La Mancha (Albacete, Spain) working on different aspects of HCV infection including NS5B HCV polymerase. Currently, Dr Mas is an Associate Professor of Microbiology (School of Pharmacy, University of Castilla-La Mancha, Spain) and the coordinator of the Molecular Medicine research group at Institute for Biomedicine Research. Research interest are viral polymerases, HCV polymerase, viral-host interactions.
Dr. Abdul Waheed is a Staff Scientist in Dr. Eric Freeds lab in the Virus-Cell Interaction Section, HIV Drug Resistance Program, NCI-Frederick. He received his Ph.D. in Membrane Biochemistry from the University of the Ryukyus, Okinawa, Japan in 1999. During his postdoctoral fellow at Tokyo Metropolitan Institute of Gerontology, Tokyo. Dr. Waheed showed the specific binding of theta-toxin (perfringolysin O) to cholesterol in the lipid rafts. He joined the National Institute of Diabetes and Digestive and Kidney Diseases in 2001, where he worked on the role of lipid rafts in G-protein signaling. Since 2003 he is working on host-factors involved
Dr. Abdul Waheed is a Staff Scientist in Dr. Eric Freeds lab in the Virus-Cell Interaction Section, HIV Drug Resistance Program, NCI-Frederick. He received his Ph.D. in Membrane Biochemistry from the University of the Ryukyus, Okinawa, Japan in 1999. During his postdoctoral fellow at Tokyo Metropolitan Institute of Gerontology, Tokyo. Dr. Waheed showed the specific binding of theta-toxin (perfringolysin O) to cholesterol in the lipid rafts. He joined the National Institute of Diabetes and Digestive and Kidney Diseases in 2001, where he worked on the role of lipid rafts in G-protein signaling. Since 2003 he is working on host-factors involved in HIV-1 replication and small molecule inhibitors of HIV-1 replication. Dr. Waheed was appointed as Lead Guest Editor for a special issue of Molecular Biology International on Host-Pathogen Interactions of Retroviruses in 2012. He also serves as an Editorial Board member of Journal of Venereology and The Scientific World Journal.
Dr. Radwan KASSIR is a Bariatric surgeon in the Department of General and Bariatric surgery at university hospital center of Saint-Etienne, France. He obtained the masters degree of Research in 2011. His fields of interests are: digestive and bariatric surgery and surgical oncology. His research focuses on the effects of Vagus Nerve Stimulation on Weight Loss and Associated Disorders. He is creator of application Scan abdo for iphone and android. Dr Kassir is director of collection : qroc en poche (28 medical books, publisher vernazobres-grego). He is author of 8 books of medicine published in Europe. He has authored more
Dr. Radwan KASSIR is a Bariatric surgeon in the Department of General and Bariatric surgery at university hospital center of Saint-Etienne, France. He obtained the masters degree of Research in 2011. His fields of interests are: digestive and bariatric surgery and surgical oncology. His research focuses on the effects of Vagus Nerve Stimulation on Weight Loss and Associated Disorders. He is creator of application Scan abdo for iphone and android. Dr Kassir is director of collection : qroc en poche (28 medical books, publisher vernazobres-grego). He is author of 8 books of medicine published in Europe. He has authored more than 30 peer-reviewed articles with a focus on digestive and bariatric surgery. He has served as reviewer of over 10 international journals such as International Journal of Surgery case reports, World Journal of Emergency Surgery, British Medical Journal BMJ, case reports, World Journal of Surgery.
Hai-Bo Wang, Ph.D, is Associate Professor of Peking University Clinical Research Institute (PUCRI) in Peking University Health Science Center (PUHSC). He graduated from Tongji Medical College, Huazhong University of Science and Technology for Bachelor degree (Preventive Medicine) in 2004, and obtained both his Master and Ph.D degree (Epidemiology and Statistics) from Chinese Center for Disease Control and Prevention (China CDC). Dr. Wang jointed PUCRI in 2014 after working in China CDC for 3 years. His research focuses on clinical cancer research (including cancer screening, risk factors for cancer and cancer treatment etc) and infectious disease (HIV/AIDS, polio, measles and pertussis
Hai-Bo Wang, Ph.D, is Associate Professor of Peking University Clinical Research Institute (PUCRI) in Peking University Health Science Center (PUHSC). He graduated from Tongji Medical College, Huazhong University of Science and Technology for Bachelor degree (Preventive Medicine) in 2004, and obtained both his Master and Ph.D degree (Epidemiology and Statistics) from Chinese Center for Disease Control and Prevention (China CDC). Dr. Wang jointed PUCRI in 2014 after working in China CDC for 3 years. His research focuses on clinical cancer research (including cancer screening, risk factors for cancer and cancer treatment etc) and infectious disease (HIV/AIDS, polio, measles and pertussis etc). His main work is project designing and development, and Dr. Wang is currently working on several research projects, such as acute lymphoblastic leukemia, malignant salivary gland tumors, cervical cancer etc. He has published over 50 research papers in NEJM, JAIDS, plos one etc.
Lihua Wang completed Postdoctoral scholar (Jan 2009-Oct 2009) from University of Alabama at Birmingham, Birmingham, Alabama. U.S.A. His reserch interests are Molecular diagnosis of emerging or reemerging infectious pathogens; Antiviral drug screening and vaccine development, basic research in viral gene structure and function.
Lihua Wang completed Postdoctoral scholar (Jan 2009-Oct 2009) from University of Alabama at Birmingham, Birmingham, Alabama. U.S.A. His reserch interests are Molecular diagnosis of emerging or reemerging infectious pathogens; Antiviral drug screening and vaccine development, basic research in viral gene structure and function.
Dr. James Ayukekbong holds a bachelor degree in Medical laboratory science and dual masters degree in Molecular Biology and Biomedicine. He obtained his PhD in Medical science from the University of Goteborg in Sweden and he is currently a senior research scientist at the public health agency of Canada. His major scientific breakthrough is the discovery of a new enterovirus designated as enterovirus A119. He is also pioneer of norovirus research in Cameroon and has made significant contributions on the seasonality, dynamics of circulation and population herd immunity of these viruses. This knowledge is embedded in his book Epidemiology of
Dr. James Ayukekbong holds a bachelor degree in Medical laboratory science and dual masters degree in Molecular Biology and Biomedicine. He obtained his PhD in Medical science from the University of Goteborg in Sweden and he is currently a senior research scientist at the public health agency of Canada. His major scientific breakthrough is the discovery of a new enterovirus designated as enterovirus A119. He is also pioneer of norovirus research in Cameroon and has made significant contributions on the seasonality, dynamics of circulation and population herd immunity of these viruses. This knowledge is embedded in his book Epidemiology of enteric viruses in Cameroon (ISBN: 978-3-659-24111-6). He is a reviewer to several scientific journals within the field of virology. His professional memberships include; Swedish society of virologists, Swedish association of medical microbiologists, the Cameroon association of Medical Laboratory scientists amongst other. His research interest is on the molecular epidemiology and evolution of human viruses.
Guangyu Li, MD, PhD is Assistant Professor at East Tennessee State Universitys Quillen College of Medicine in Johnson City. He completed postdoctoral fellowships in both pathology and infectious diseases at the University of Texas. Prior to joining the faculty in the Department of Internal Medicines Division of Infectious Diseases, Dr. Li was an instructor at the University of Texas Medical Branch in Galveston. Dr. Li moved to the U.S. from his native China after earning his M.D. in 1997 and his Ph.D. in Infectious Diseases in 2005. Since then he has mentored two medicine fellows, one Ph.D. candidate, and three
Guangyu Li, MD, PhD is Assistant Professor at East Tennessee State Universitys Quillen College of Medicine in Johnson City. He completed postdoctoral fellowships in both pathology and infectious diseases at the University of Texas. Prior to joining the faculty in the Department of Internal Medicines Division of Infectious Diseases, Dr. Li was an instructor at the University of Texas Medical Branch in Galveston. Dr. Li moved to the U.S. from his native China after earning his M.D. in 1997 and his Ph.D. in Infectious Diseases in 2005. Since then he has mentored two medicine fellows, one Ph.D. candidate, and three medical school students. He is a member of the Scientific Society of Sigma Xi, the American Society for Virology, and the American Society of Microbiology. Dr. Lis research interests include the pathogenesis of viruses-particularly the human immunodeficiency virus (HIV) and those that cause hepatitis, encephalitis, and hemorrhagic fevers. A seasoned researcher, Dr. Lis current projects are designed to assess the role of an identified gene, CD63, to HIV-1 replication in primary human macrophages, and generating and identifying nuclease-resistant phosphorothioate thioaptamers against hepatitis C infection. Along with his colleague, Monique Ferguson, Dr. Li was awarded a non-provisional patent in 2010 for detection of hepatitis C virus RNA. Author of more than 100 peer-reviewed journal articles, Dr. Li sits on the editorial board of the publication, Journal of Bioterrorism and Biodefense, and he has served as a reviewer for several additional publications, including the Journal of Applied Microbiology and Hepatic Medicine: Evidence and Research. My research is focused on the several clincal diseases, such as AIDS, Hepatitis B/C, HRFS, etc.
Dr. Pengcheng Han obtained his MD from Beijing Medical University and Ph.D degree from the University of Utah. After his postdoctoral training at Hotchkiss Brain Institute, he worked as senior research associate at University of Calgary, and Barrow Neurological Institute. Currently he is assistant professor (research track) at Dignity Health St Josephs Hospital and Medical Center in Arizona. Dr. Hans research focuses on study neuropeptides, Alzheimer disease and neurodegeneration, neuroprotection and neuroimmunology. His other research project includes the energy metabolism, mitochondria and neural excitability in neurological disorders.
Dr. Pengcheng Han obtained his MD from Beijing Medical University and Ph.D degree from the University of Utah. After his postdoctoral training at Hotchkiss Brain Institute, he worked as senior research associate at University of Calgary, and Barrow Neurological Institute. Currently he is assistant professor (research track) at Dignity Health St Josephs Hospital and Medical Center in Arizona. Dr. Hans research focuses on study neuropeptides, Alzheimer disease and neurodegeneration, neuroprotection and neuroimmunology. His other research project includes the energy metabolism, mitochondria and neural excitability in neurological disorders.
Dr. Dongsheng Xu is a medical doctor in neurology and infectious diseases. He had 12-years clinical practices in China. Since 2000, He worked on my research in virus-related cancer, HIV associated dementia, viral immunology and neural stem cells in University of Nebraska Medical Center (UNMC) and University of Nebraska-Lincoln (UNL) respectively. He is an assistant professor in viral related research and stem cell at UNMC, and he also has a clinical appointment in Tongji University in Shanghai, China now. The one of major goals for his researches is to develop the inhibitors to negatively affect virus-related cancer metastasis. Another goal
Dr. Dongsheng Xu is a medical doctor in neurology and infectious diseases. He had 12-years clinical practices in China. Since 2000, He worked on my research in virus-related cancer, HIV associated dementia, viral immunology and neural stem cells in University of Nebraska Medical Center (UNMC) and University of Nebraska-Lincoln (UNL) respectively. He is an assistant professor in viral related research and stem cell at UNMC, and he also has a clinical appointment in Tongji University in Shanghai, China now. The one of major goals for his researches is to develop the inhibitors to negatively affect virus-related cancer metastasis. Another goal is to search immune-related chemokines for modulating dysfunctional microenvironment in Alzheimers disease and spinal cord injury.
Dr. Song Gao obtained his PhD from the Institute of Matera Media, Peking Union Medical College in medicinal chemistry. After his postdoctoral training in the University of Arizona and the University of Houston, he works as an assistant professor in the College of Pharmacy, the University of Houston. Dr. Gao has a broad background in pharmaceutics and medicinal chemistry, with specific training in bioactive natural product identification from herbal, organic synthesis, drug absorption, metabolism, and drug bioanalysis. Dr. Gaos research interest focuses on improving efficacy and reducing side effect of drug candidate through intervening the bioavailability.
Dr. Song Gao obtained his PhD from the Institute of Matera Media, Peking Union Medical College in medicinal chemistry. After his postdoctoral training in the University of Arizona and the University of Houston, he works as an assistant professor in the College of Pharmacy, the University of Houston. Dr. Gao has a broad background in pharmaceutics and medicinal chemistry, with specific training in bioactive natural product identification from herbal, organic synthesis, drug absorption, metabolism, and drug bioanalysis. Dr. Gaos research interest focuses on improving efficacy and reducing side effect of drug candidate through intervening the bioavailability.
Dr. Sharma has a Ph.D. in Medical Microbiology from University of Delhi. He has completed his post-doctoral fellowship training in the area of retrovirus drug resistance and pathogenesis at Harvard School of Medicine and affiliated institution such as Harvard School of Public Health, Dana Farber Cancer Institute and Beth Israel Deaconess Hospital. He served as a junior faculty in Division of Infectious Diseases, Beth Israel Deaconess Hospital, Harvard school of Medicine. Currently, Dr. Sharma is an Assistant Professor in the Department of Microbiology and Immunology at Emory University and Research Microbiologist at Atlanta VA Medical Center. The major of focus
Dr. Sharma has a Ph.D. in Medical Microbiology from University of Delhi. He has completed his post-doctoral fellowship training in the area of retrovirus drug resistance and pathogenesis at Harvard School of Medicine and affiliated institution such as Harvard School of Public Health, Dana Farber Cancer Institute and Beth Israel Deaconess Hospital. He served as a junior faculty in Division of Infectious Diseases, Beth Israel Deaconess Hospital, Harvard school of Medicine. Currently, Dr. Sharma is an Assistant Professor in the Department of Microbiology and Immunology at Emory University and Research Microbiologist at Atlanta VA Medical Center. The major of focus of Dr. Sharma's research include understanding the interaction of HIV-1 MDR mutations in viral replication and pathogenesis. Dr. Sharma has been awarded NIH RO1 and VA MERIT grants to study the role of drug resistance mutations in HIV replication fitness. Dr. Sharma has published several key papers in the area of HIV replication fitness.
Dr. Sztuba-Solinska did her initial research in plant molecular biology in the lab of Dr. Maria Goska at Plant Breeding and Acclimatization Institute Department of Genetics and Breeding of Root Crops, Laboratory of Biotechnology in Poland. During that time she studied the application of molecular marker techniques for investigation of the polymorphism of mitochondrial DNA in multigerm populations of sugar beet. Further, she pursued her doctoral research in the lab of Dr. Jozef J. Bujarski at Northern Illinois University, DeKalb, IL - USA. She obtained her doctoral degree in May 2011. During her PhD, she studied the molecular mechanisms of
Dr. Sztuba-Solinska did her initial research in plant molecular biology in the lab of Dr. Maria Goska at Plant Breeding and Acclimatization Institute Department of Genetics and Breeding of Root Crops, Laboratory of Biotechnology in Poland. During that time she studied the application of molecular marker techniques for investigation of the polymorphism of mitochondrial DNA in multigerm populations of sugar beet. Further, she pursued her doctoral research in the lab of Dr. Jozef J. Bujarski at Northern Illinois University, DeKalb, IL - USA. She obtained her doctoral degree in May 2011. During her PhD, she studied the molecular mechanisms of RNA-RNA recombination that occur in RNA viruses by using Brome Mosaic Bromovirus (BMV) as a model system, from both the virus and the host stand points. Subsequently, she joined Dr. Stuart F.J. Le Grice's lab at the HIV Drug Resistance Program, Center for Cancer Research, NCI/NIH, Frederick, MD- USA, as a visiting fellow.Her current work focuses on elucidation of the viral RNA structural conformation and function through the implementation of high-throughput chemoenzymatic methodsand implementation of bioinformatics tools. She focuses on identification of small molecules that selectively bind to cis- and trans- acting RNA structures, which remains an important challenge in developing potent and specific RNA structure-based antiviral/anticancer therapeutics.
I obtained Biomedical Sciences degree with First-Class honour from the National University of Malaysia in 2001 and PhD in Medical Sciences from the University of Malaya (pathology and virology) in 2007. Upon completing my PhD, I joined the Department of Molecular Medicine Department, Mayo Clinic College of Medicine, Rochester, Minnesota to work as a postdoctoral fellow, working with the use of oncolytic measles virus in lymphoma treatment (virotherapy) together withProfessor Roberto Cattaneo. In 2010, I joined the Center for Molecular Medicine, Karolinska Institutet, Solna, Sweden for the second postdoctoral fellow to investigate the role of cytomegalovirus in the pathogenesis of
I obtained Biomedical Sciences degree with First-Class honour from the National University of Malaysia in 2001 and PhD in Medical Sciences from the University of Malaya (pathology and virology) in 2007. Upon completing my PhD, I joined the Department of Molecular Medicine Department, Mayo Clinic College of Medicine, Rochester, Minnesota to work as a postdoctoral fellow, working with the use of oncolytic measles virus in lymphoma treatment (virotherapy) together withProfessor Roberto Cattaneo. In 2010, I joined the Center for Molecular Medicine, Karolinska Institutet, Solna, Sweden for the second postdoctoral fellow to investigate the role of cytomegalovirus in the pathogenesis of cardiovascular disease. I was appointed as a research associate or assistant professor in June 2013 in viral pathogenesis in chronic inflammation and cardiovascular diseases. My current focus is to better understand the role of cytomegalovirus in a myriad of diseases, including cancer and the basic virological aspects of the virus.
Dr. Mario Arciello is a researcher of 'Sapienza' University of Rome. After graduation in 2004 at 'Tor Vergata' University of Rome with an experimental thesis in Biochemistry. He focused his scientific activity on the copper homeostasis alteration in cells models for Menkes and Wilson diseases, mainly on its role in the mitochondrial dysfunctions and oxidative stress occurrence. Then he studied these topics also in the etiopathogenesis of neurodegenerative disorders like Alzheimers disease (AD) and the familial form of Amyotrophic Lateral Sclerosis (fALS). After the PhD degree in Cellular and Molecular Biology in the 2009 at 'Tor Vergata' University of Rome,
Dr. Mario Arciello is a researcher of 'Sapienza' University of Rome. After graduation in 2004 at 'Tor Vergata' University of Rome with an experimental thesis in Biochemistry. He focused his scientific activity on the copper homeostasis alteration in cells models for Menkes and Wilson diseases, mainly on its role in the mitochondrial dysfunctions and oxidative stress occurrence. Then he studied these topics also in the etiopathogenesis of neurodegenerative disorders like Alzheimers disease (AD) and the familial form of Amyotrophic Lateral Sclerosis (fALS). After the PhD degree in Cellular and Molecular Biology in the 2009 at 'Tor Vergata' University of Rome, he studied the HCV infection and non-alcoholic fatty liver disease (NAFLD), in particular: the role of oxidative stress, mitochondrial dysfunctions, morphogens and tumor suppressors signaling pathways. Dr Arciello is member of Associazione Italiana per lo Studio del Fegato (AISF) and of European Association for the Study of the Liver (EASL).His resarch interests are Copper homeostasis, Menkes and Wilsons Diseases, Liver diseases (e.g. NAFLD and HCV infection), Metabolic diseases, Neurodegeneration, Oxidative stress and antioxidant defenses, Lipid metabolism, Glucose metabolism, Healthy effects of natural polyphenols, Impact of pollution on metabolism.
Dr. Manoosak Wongphatcharachai obtained his doctoral degree in molecular epidemiology of influenza A viruses at the Department of Veterinary Public Health, Chulalongkorn University, Thailand. He also worked as a Research Assistance at the Center of Excellence for Emerging and Re-emerging Infectious Disease in Animals, Faculty of Veterinary Science, Chulalongkorn University. In 2010, he came to U.S. as a visiting scholar at the College of Veterinary Medicine, University of Minnesota to develop high affinity DNA aptamers against influenza H3N2 viruses (U.S. patented). He is currently working as a Post-Doctoral Associate at the University of Minnesota-BioTechnology Institute. He is now working on
Dr. Manoosak Wongphatcharachai obtained his doctoral degree in molecular epidemiology of influenza A viruses at the Department of Veterinary Public Health, Chulalongkorn University, Thailand. He also worked as a Research Assistance at the Center of Excellence for Emerging and Re-emerging Infectious Disease in Animals, Faculty of Veterinary Science, Chulalongkorn University. In 2010, he came to U.S. as a visiting scholar at the College of Veterinary Medicine, University of Minnesota to develop high affinity DNA aptamers against influenza H3N2 viruses (U.S. patented). He is currently working as a Post-Doctoral Associate at the University of Minnesota-BioTechnology Institute. He is now working on metagenomics by using next generation sequencing (Illumina platforms) to study microbial community structures and the projects to improve organic agriculture farms in Minnesota. He also serves as a reviewer of the journal Combinatorial Chemistry & High Throughput Screening and the Biomedical and Environmental Sciences.
I am currently the Genomics Platform Lead for R&D IT at Monsanto. In this role my primary focus is the development of an enterprise level IT platform for storage, visualization, mining and analysis of genomic data. My research interests include genomics, transcriptomics, epigenomics and metagenomics. Our platform focuses on genomics in plants, insects and microbes. My graduate research at the Ohio State University also focused on a microbe Human Cytomegalovirus a major cause of congenital defects in humans. My experience with the characterization of the Human Cytomegalovirus transcriptome by creating a cDNA library and Sanger sequencing followed by a predominantly
I am currently the Genomics Platform Lead for R&D IT at Monsanto. In this role my primary focus is the development of an enterprise level IT platform for storage, visualization, mining and analysis of genomic data. My research interests include genomics, transcriptomics, epigenomics and metagenomics. Our platform focuses on genomics in plants, insects and microbes. My graduate research at the Ohio State University also focused on a microbe Human Cytomegalovirus a major cause of congenital defects in humans. My experience with the characterization of the Human Cytomegalovirus transcriptome by creating a cDNA library and Sanger sequencing followed by a predominantly manual analysis process impressed upon me the need for better data analysis tools for biological data. In addition to that the amount of data being generated keeps growing as sequencing technologies become more sophisticated and less expensive. I believe that understanding this data is key to understanding biological phenomena like host pathogen (microbe) interactions including immune responses.
My overarching area of interest and expertise is cancer epidemiology. I am particularly interested in infection and immunoepidemiology and haematopoietic malignancies after having worked in the Infection and Immunoepidemiology Branch within the National Cancer Institute, USA. I am also interested in the aetiology of Barretts oesophagus and oesophageal adenocarcinoma, the focus of my PhD thesis. Recently I have undertaken research in pharmacoepidemiology investigating medication usage and risk of head and neck cancer, malignant melanoma, cervical cancer and multiple myeloma. My research interests are Infection and immunoepidemiology, Human Papilomavirus, Cancer.
My overarching area of interest and expertise is cancer epidemiology. I am particularly interested in infection and immunoepidemiology and haematopoietic malignancies after having worked in the Infection and Immunoepidemiology Branch within the National Cancer Institute, USA. I am also interested in the aetiology of Barretts oesophagus and oesophageal adenocarcinoma, the focus of my PhD thesis. Recently I have undertaken research in pharmacoepidemiology investigating medication usage and risk of head and neck cancer, malignant melanoma, cervical cancer and multiple myeloma. My research interests are Infection and immunoepidemiology, Human Papilomavirus, Cancer.
Daniele Focosi, MD, is currently a resident virologist and transplant immunologist at Azienda Ospedaliera Universitaria Pisana, since May 2010. Dr. Focosi was previously a physician in the Division of Hematology at University of Pisa, Italy. He was also aresearch fellow at International Centre for Genetic Engineering and Biotechnology (ICGEB), Molecular Immunology Group, in Trieste; the Collegio Ghislieri in Pavia, Italy; and the University of Pisa Center for Clinical Use of Stem Cells (CUCCS). Dr. Focosi has authored 87 scientific articles indexed in PubMed, with an overall impact factor of over 700 and an hc-index of 11. He has given 32
Daniele Focosi, MD, is currently a resident virologist and transplant immunologist at Azienda Ospedaliera Universitaria Pisana, since May 2010. Dr. Focosi was previously a physician in the Division of Hematology at University of Pisa, Italy. He was also aresearch fellow at International Centre for Genetic Engineering and Biotechnology (ICGEB), Molecular Immunology Group, in Trieste; the Collegio Ghislieri in Pavia, Italy; and the University of Pisa Center for Clinical Use of Stem Cells (CUCCS). Dr. Focosi has authored 87 scientific articles indexed in PubMed, with an overall impact factor of over 700 and an hc-index of 11. He has given 32 oral and 45 poster presentations at national and international conferences. He has received awards from the European Federation of Immunogenetics, the Italian Society for Hematology, the Italian Bone Marrow Donor Association, the Italian Interregional Transplant Association, and the Italian Society for Experimental Hematology.His research interests are lymphoma, leukemia, anti-idiotype vaccine, iPSC, monoclonal antibodies, opportunistic infections, PML, progressive multifocal leukoencephalopathy, cytokines, ELISpot,CDC, HLA.
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97